compound thienopyrimidinone. Methods: In the present study, a series of C-2 substituted derivatives of thienopyrimidinone, namely L1–L16, were synthesized, and their inhibitory effects on FGFR1 were evaluated. The anti-proliferative activities of these compounds were assessed by MTT assay. Results: Among the novel derivatives, L11 was found to exert remarkable FGFR1 inhibitory activity (79.93% at 10 µM) and
背景:
噻吩并
嘧啶酮是一种新设计的选择性成纤维细胞生长因子受体1(FGFR1)
抑制剂,具有出色的抗癌作用。 目的:本研究的目的是通过修饰先导化合物
噻吩并
嘧啶酮来设计和合成更好的FGFR1
抑制剂。 方法:本研究合成了一系列
噻吩并
嘧啶酮的C-2取代衍
生物,即L1-L16,并评价了它们对FGFR1的抑制作用。这些化合物的抗增殖活性通过M
TT分析评估。 结果:在新的衍
生物中,发现L11具有显着的FGFR1抑制活性(在10 µM时为79.93%)和抗增殖活性,在过表达FGFR1的
细胞系H460中IC50值为2.1、2.5和3.5 µM ,HT-1197和B16F10。 结论:我们新合成的
噻吩并
嘧啶酮衍
生物可能是潜在的FGFR1
抑制剂,有望作为新型抗癌药开发。